Aspira Women's Health Inc. (AWHL): Submission of Matters to a Vote of Security Holders
Aspira Women's Health Inc. (AWHL) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Aspira Women's Health Inc._June 17, 2026 Aspira Women's Health Inc. 0000926617 false 0000926617 2026-01-30 2026-01-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
How this was made
The 30-second read
Why it matters
The disclosed items are (1) election of six directors, (2) advisory approval of named executive officer compensation, (3) approval to amend the 2019 Stock Incentive Plan by adding 5,000,000 authorized shares (total 9,532,818), and (4) ratification of BDO USA, P.C. as independent auditor for 2026.
Market read
Traders may monitor the stock-incentive plan authorization for longer-term dilution expectations, but there is no immediate earnings/guidance or deal catalyst.
What to watch
Because the filing is OTC-listed and provides only vote tallies, liquidity/float dynamics may dominate any price reaction more than the plan authorization itself.
Background
Form 8-K Item 5.07 reports matters submitted to a vote of security holders following the company’s 2026 annual meeting.
Ticker impact
Aspira Women’s Health reported 2026 annual meeting voting results, including director elections and approval of a 5,000,000-share increase to its 2019 stock incentive plan.
Likely limited near-term impact; any effect would be indirect via dilution expectations rather than a new catalyst.
The filing is an 8-K Item 5.07 with final vote counts and plan-share authorization, but it does not include earnings, guidance, financing, M&A, or regulatory outcomes.
Market effects
Minimal; this is company-specific governance/plan authorization with no sector-wide signal.
None indicated.
None indicated.
Counterpoint
The stock-incentive plan share increase could modestly raise dilution over time, which may matter for valuation-sensitive holders even if the event is routine.
Key entities
- companyAspira Women’s Health Inc.
OTC-listed issuer that held its 2026 annual meeting and reported final voting results on directors, executive comp (advisory), and an amended stock incentive plan.
- auditorBDO USA, P.C.
Independent registered public accounting firm ratified for the year ending December 31, 2026.
